Literature DB >> 29160530

Zika virus infection followed by a first episode of psychosis: another flavivirus leading to pure psychiatric symptomatology.

Gabriel Elias Corrêa-Oliveira1, Julia Lopes do Amaral1, Benedito Antônio Lopes da Fonseca2, Cristina Marta Del-Ben1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29160530      PMCID: PMC7111412          DOI: 10.1590/1516-4446-2017-2308

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


× No keyword cloud information.
Zika virus (ZIKV), a flavivirus primarily transmitted by Aedes mosquitoes, represents a major public health concern. ZIKV infection, previously considered a self-limited febrile exanthematic disease, leads to serious neurologic complications.1 Microcephaly and extensive brain damage can result from congenital ZIKV infection. An association with Guillain-Barre Syndrome was suggested after the French Polynesia outbreak,2 and reports from endemic areas suggest that acute ZIKV infection leads to numerous central nervous system (CNS) complications. Considering the complexity of CNS function, we can expect a variety of clinical manifestations, even purely psychiatric symptoms. A 17-year-old boy was transferred to our psychiatric emergency ward for evaluation of a first-episode psychosis (FEP). He had no significant health history or previous psychiatric history. Ten days prior to admission, he suddenly presented paranoid delusions and vivid auditory, somatic and olfactory hallucinations. He showed intense anxiety and panic-like symptoms, alternating with moments of inadequate behavioral disinhibition. Symptoms also included sleeplessness, increased speech production, vocal mannerisms and refusal to eat. A distinct period of altered mood was negated. Upon admission he was fully conscious with no attention deficits, disoriented about the time and place, afraid, suspicious and speaking incoherently. Physical and neurological exams were otherwise normal. Initial workup included hematological, toxicological, neuroradiologic and electroencephalographic assessments, which were all within normal range. A febrile rash – followed by pruritus, myalgia, arthralgia, periocular pain and posterior cervical adenopathy, which began 14 days before the onset of the behavioral symptoms and remitted after a week – was then reported by his parents. We extended the investigation to rule out other medical conditions leading to the psychotic episode. All CSF parameters were within the normal range. In peripheral blood we detected positive dengue virus (DENV) in ELISA, IgM, and IgG tests; the NS1 antigen was undetectable and RT-PCR was negative for DENV. RT-PCRs for ZIKV resulted positive in multiple blood samples. An intense cross-reaction was observed across DENV and ZIKV ELISA titers,3,4 leading us to conclude that this was the case. After five days of Haloperidol with no response, the prescription was changed to Risperidone 2 mg/day and remission was achieved in three days. The patient was discharged and medication was tapered off after 3 weeks. No relapse in symptoms was noted during one year of follow-up in our specialized FEP outpatient service. To the best of our knowledge, this is the first report in which psychiatric symptoms were the only complication of acute ZIKV infection. There is much evidence of psychiatric symptomatology in viral infections. Dengue-related manic and psychotic episodes have been described in which symptoms suggesting encephalitis or encephalopathy were not seen – thus supporting flavivirus’ role in inducing purely behavioral symptoms. Cases in which DENV infections have led to neuropsychiatric complications are numerous, well established in the literature and more commonly diagnosed than in regular clinical practice.5 Neuroimmune mechanisms leading to psychosis during acute CNS stress is an open and prolific field for research. On the clinical front, mental health professionals dealing with emergency psychiatry and FEP must have a high grade of suspicion to avoid underrecognizing particular – and self-limited – conditions.

Disclosure

The authors report no conflicts of interest.
  5 in total

1.  Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.

Authors:  Karin Stettler; Martina Beltramello; Diego A Espinosa; Victoria Graham; Antonino Cassotta; Siro Bianchi; Fabrizia Vanzetta; Andrea Minola; Stefano Jaconi; Federico Mele; Mathilde Foglierini; Mattia Pedotti; Luca Simonelli; Stuart Dowall; Barry Atkinson; Elena Percivalle; Cameron P Simmons; Luca Varani; Johannes Blum; Fausto Baldanti; Elisabetta Cameroni; Roger Hewson; Eva Harris; Antonio Lanzavecchia; Federica Sallusto; Davide Corti
Journal:  Science       Date:  2016-07-14       Impact factor: 47.728

Review 2.  Zika Virus as an Emerging Global Pathogen: Neurological Complications of Zika Virus.

Authors:  J David Beckham; Daniel M Pastula; Aaron Massey; Kenneth L Tyler
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 18.302

3.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

Authors:  Van-Mai Cao-Lormeau; Alexandre Blake; Sandrine Mons; Stéphane Lastère; Claudine Roche; Jessica Vanhomwegen; Timothée Dub; Laure Baudouin; Anita Teissier; Philippe Larre; Anne-Laure Vial; Christophe Decam; Valérie Choumet; Susan K Halstead; Hugh J Willison; Lucile Musset; Jean-Claude Manuguerra; Philippe Despres; Emmanuel Fournier; Henri-Pierre Mallet; Didier Musso; Arnaud Fontanet; Jean Neil; Frédéric Ghawché
Journal:  Lancet       Date:  2016-03-02       Impact factor: 79.321

4.  Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007.

Authors:  Robert S Lanciotti; Olga L Kosoy; Janeen J Laven; Jason O Velez; Amy J Lambert; Alison J Johnson; Stephanie M Stanfield; Mark R Duffy
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

Review 5.  Global research priorities for infections that affect the nervous system.

Authors:  Chandy C John; Hélène Carabin; Silvia M Montano; Paul Bangirana; Joseph R Zunt; Phillip K Peterson
Journal:  Nature       Date:  2015-11-19       Impact factor: 49.962

  5 in total
  6 in total

Review 1.  Comparative overview of emerging RNA viruses: Epidemiology, pathogenesis, diagnosis and current treatment.

Authors:  Ishani Chakrabartty; Maryam Khan; Saurov Mahanta; Hitesh Chopra; Manish Dhawan; Om Prakash Choudhary; Shabana Bibi; Yugal Kishore Mohanta; Talha Bin Emran
Journal:  Ann Med Surg (Lond)       Date:  2022-06-11

Review 2.  Mucocutaneous Features of Zika-a Review.

Authors:  Xuan Qi Koh; Nisha Suyien Chandran; Paul Anantharajah Tambyah
Journal:  Curr Infect Dis Rep       Date:  2019-04-30       Impact factor: 3.663

3.  Zika Virus Alters DNA Methylation of Neural Genes in an Organoid Model of the Developing Human Brain.

Authors:  Sylvie Janssens; Michael Schotsaert; Rahul Karnik; Vinod Balasubramaniam; Marion Dejosez; Alexander Meissner; Adolfo García-Sastre; Thomas P Zwaka
Journal:  mSystems       Date:  2018-02-06       Impact factor: 6.496

4.  COVID-19-Induced Psychosis and Suicidal Behavior: Case Report.

Authors:  Mason Chacko; Asha Job; Fred Caston; Prem George; Adeeb Yacoub; Ricardo Cáceda
Journal:  SN Compr Clin Med       Date:  2020-09-26

5.  Zika virus-induced TNF-α signaling dysregulates expression of neurologic genes associated with psychiatric disorders.

Authors:  Po-Lun Kung; Tsui-Wen Chou; Marissa Lindman; Nydia P Chang; Irving Estevez; Benjamin D Buckley; Colm Atkins; Brian P Daniels
Journal:  J Neuroinflammation       Date:  2022-04-24       Impact factor: 9.587

6.  A systematic review and evaluation of Zika virus forecasting and prediction research during a public health emergency of international concern.

Authors:  Pei-Ying Kobres; Jean-Paul Chretien; Michael A Johansson; Jeffrey J Morgan; Pai-Yei Whung; Harshini Mukundan; Sara Y Del Valle; Brett M Forshey; Talia M Quandelacy; Matthew Biggerstaff; Cecile Viboud; Simon Pollett
Journal:  PLoS Negl Trop Dis       Date:  2019-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.